These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2271046)

  • 21. Recent advances in understanding haemochromatosis: a transition state.
    Robson KJ; Merryweather-Clarke AT; Cadet E; Viprakasit V; Zaahl MG; Pointon JJ; Weatherall DJ; Rochette J
    J Med Genet; 2004 Oct; 41(10):721-30. PubMed ID: 15466004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study.
    Ellervik C; Mandrup-Poulsen T; Nordestgaard BG; Larsen LE; Appleyard M; Frandsen M; Petersen P; Schlichting P; Saermark T; Tybjaerg-Hansen A; Birgens H
    Lancet; 2001 Oct; 358(9291):1405-9. PubMed ID: 11705485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hereditary (primary) haemochromatosis.
    Kelly I; Dick R
    BMJ; 1990 Oct; 301(6755):815. PubMed ID: 2224275
    [No Abstract]   [Full Text] [Related]  

  • 24. Hereditary haemochromatosis and blood donation.
    Worwood M; Darke C; Trenchard P
    BMJ; 1991 Mar; 302(6776):593. PubMed ID: 2021732
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic explanations, discrimination and chronic illness: A qualitative study on hereditary haemochromatosis in Germany.
    Manz U
    Chronic Illn; 2016 Dec; 12(4):308-319. PubMed ID: 27178546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hereditary haemochromatosis: to screen or not to screen?
    Olynyk JK; Trinder D; Milward E
    J Hepatol; 2005 Jul; 43(1):9-10. PubMed ID: 15923055
    [No Abstract]   [Full Text] [Related]  

  • 27. Hereditary haemochromatosis should be more widely known about.
    Rosenberg W; Howell M; Roderick P; Eccles D; Day I
    BMJ; 1999 May; 318(7196):1486-7. PubMed ID: 10346785
    [No Abstract]   [Full Text] [Related]  

  • 28. [Prevalence of hemochromatosis-associated mutations in the hemochromatosis gene in the Danish population].
    Larsen LE; Ellervik C; Appleyard M; Nordestgaard BG; Birgens H; Tybjaerg-Hansen A
    Ugeskr Laeger; 2002 Sep; 164(39):4545-7. PubMed ID: 12380399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary haemochromatosis: never seen a case?
    Emery J; Rose P
    Br J Gen Pract; 2001 May; 51(466):347-8. PubMed ID: 11360695
    [No Abstract]   [Full Text] [Related]  

  • 30. Iron overload in light of the identification of a haemochromatosis gene.
    Hollán S
    Haematologia (Budap); 1997; 28(3):109-16. PubMed ID: 9283910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morbidity and mortality in first-degree relatives of C282Y homozygous probands with clinically detected haemochromatosis compared with the general population: the HEmochromatosis FAmily Study (HEFAS).
    Jacobs EM; Hendriks JC; Marx JJ; van Deursen CT; Kreeftenberg HG; de Vries RA; Stalenhoef AF; Verbeek AL; Swinkels DW
    Neth J Med; 2007 Dec; 65(11):425-33. PubMed ID: 18079565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pituitary gland and hereditary haemochromatosis.
    Wahid S; Ball S
    Lancet; 2001 Jan; 357(9250):115. PubMed ID: 11197399
    [No Abstract]   [Full Text] [Related]  

  • 33. Dual diagnoses of hereditary hyperferritinaemia-cataract syndrome and hereditary haemochromatosis.
    Hughes M; Vosylius P
    Clin Lab Haematol; 2006 Oct; 28(5):357-9. PubMed ID: 16999731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Penetrance of 845G--> A (C282Y) HFE hereditary haemochromatosis mutation in the USA.
    Beutler E; Felitti VJ; Koziol JA; Ho NJ; Gelbart T
    Lancet; 2002 Jan; 359(9302):211-8. PubMed ID: 11812557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hereditary haemochromatosis: to screen or not. Conditions for screening are not yet fulfilled.
    Haddow JE; Bradley LA
    BMJ; 1999 Aug; 319(7209):531-2. PubMed ID: 10463879
    [No Abstract]   [Full Text] [Related]  

  • 37. Preventing manifestations of hereditary haemochromatosis through population based screening.
    Haddow JE; Ledue TB
    J Med Screen; 1994 Jan; 1(1):16-21. PubMed ID: 8790482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insurance agreement to facilitate genetic testing.
    Delatycki M; Allen K; Williamson R
    Lancet; 2002 Apr; 359(9315):1433. PubMed ID: 11978360
    [No Abstract]   [Full Text] [Related]  

  • 39. [Erythrocytapheresis for hereditary haemochromatosis].
    Rombout-Sestrienkova E; van Deursen CT; Janssen MC; van Kraaij MG; de Leeuw PW; Koek GH
    Ned Tijdschr Geneeskd; 2012; 156(26):A4745. PubMed ID: 22759710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterozygous recipient and donor HFE mutations associated with a hereditary haemochromatosis phenotype after liver transplantation.
    Wigg AJ; Harley H; Casey G
    Gut; 2003 Mar; 52(3):433-5. PubMed ID: 12584229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.